Kane Biotech Inc. (CVE:KNE – Get Free Report)’s stock price rose 14.3% on Thursday . The stock traded as high as C$0.04 and last traded at C$0.04. Approximately 180,000 shares changed hands during trading, an increase of 97% from the average daily volume of 91,567 shares. The stock had previously closed at C$0.04.
Kane Biotech Trading Up 14.3%
The company has a market capitalization of C$6.65 million, a price-to-earnings ratio of -0.44 and a beta of 0.23. The company has a debt-to-equity ratio of -331.42, a quick ratio of 0.39 and a current ratio of 0.80. The business’s 50-day simple moving average is C$0.04 and its 200-day simple moving average is C$0.05.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
See Also
- Five stocks we like better than Kane Biotech
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Forget Netflix—Paramount Skydance’s $3B Plan Is Turning Heads on Wall Street
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- AMD to $300 Looks Easy—Here’s Why $500 Could Be Next
- What Does a Stock Split Mean?
- $5B+ in Buybacks: What DraftKings, AppLovin, and Altria Are Telling You
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
